Institute of Experimental and Clinical Pharmacology and Toxicology

Organisation profile

About us

Welcome on the homepage of the Institute for Experimental and Clinical Pharmacology and Toxicology.

Our research focuses on the pharmacology of the brain at the interface of immune system, metabolism and cerebral blood flow. We teach pharmacology and toxicology, clinical pharmacology, and clinical environmental medicine for students of medicine, molecular life sciences and at the University of Applied Sciences.

Kind regards

Markus Schwaninger
Chairman

Our research groups:

Bridging Brain Barriers (Group Leader: Prof. Schwaninger)

Cerebral Perfusion and Metabolism (Group Leader: Dr. Wenzel)

Influence of RAAS on the Metabolic Syndrome (Group Leader: Prof. Raasch)

Interaction between Tanycytes and the Hormone Axes (Group Leader: Dr. Helge Müller-Fielitz)

Neuropeptides and Energy Homeostasis (Group Leader: Prof. Jöhren)

Neuroplasticity and Rhythms (Group Leader: Prof Marshall)

Pharmacovigilance - systematic monitoring of authorized drugs (Prof. Schwaninger & Prof. Raasch)

WATCH Group (Prof. Schwaninger & Dr. Helge Müller-Fielitz)

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Fingerprint

Dive into the research topics where Institute of Experimental and Clinical Pharmacology and Toxicology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or